Similar Items: The anti-cancer activity of a novel palladacycle, BTC2, in oestrogen receptor positive and triple negative breast cancers
- Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen‐Receptor Positive and Triple‐Negative Breast Cancer Cell Lines
- The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
- Identification and characterization of a novel Palladacycle, AJ-5, to treat advanced Melanoma and breast Cancer
- Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC)
- Lipid profile and atherogenic indices in triple-negative breast cancer
- Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer
Author: Prince, Sharon
- Identification and characterization of a novel Palladacycle, AJ-5, to treat advanced Melanoma and breast Cancer
- The role of TBX2 and the anti-cancer activity of chromomycin A5 in pancreatic ductal adenocarcinoma
- The role of the transcription factor TBX2 in breast cancer and melanoma and its regulation by the UV-induced DNA damage pathway.
- Regulation of the cyclin-dependent kinase inhibitor p21 by TBX3
- Identifying novel drugs for the treatment of rhabdomyosarcoma
- The role of T-box transcription factor TBX3 in rhabdomyosarcoma